000 | 01950 a2200529 4500 | ||
---|---|---|---|
005 | 20250517012209.0 | ||
264 | 0 | _c20160105 | |
008 | 201601s 0 0 eng d | ||
022 | _a1874-1754 | ||
024 | 7 |
_a10.1016/j.ijcard.2014.12.046 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan der Leeuw, Joep | |
245 | 0 | 0 |
_aPrediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPA. _h[electronic resource] |
260 |
_bInternational journal of cardiology _cMar 2015 |
||
300 |
_a194-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aClinical Decision-Making _xmethods |
650 | 0 | 4 |
_aCoronary Artery Disease _xdrug therapy |
650 | 0 | 4 |
_aDeath, Sudden, Cardiac _xepidemiology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aEurope _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPerindopril _xadministration & dosage |
650 | 0 | 4 |
_aPrecision Medicine _xmethods |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aOemrawsingh, Rohit M | |
700 | 1 | _avan der Graaf, Yolanda | |
700 | 1 | _aBrugts, Jasper J | |
700 | 1 | _aDeckers, Jaap W | |
700 | 1 | _aBertrand, Michel | |
700 | 1 | _aFox, Kim | |
700 | 1 | _aFerrari, Roberto | |
700 | 1 | _aRemme, Willem J | |
700 | 1 | _aSimoons, Maarten L | |
700 | 1 | _aBoersma, Eric | |
700 | 1 | _aVisseren, Frank L J | |
773 | 0 |
_tInternational journal of cardiology _gvol. 182 _gp. 194-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijcard.2014.12.046 _zAvailable from publisher's website |
999 |
_c24524052 _d24524052 |